Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic Rhinitis
Completed
Meda Pharmaceuticals
Phase 3
2006-07-01
The purpose of this study is to determine if Astepro Nasal Spray (0.1% azelastine
hydrochloride) is as safe as Astelin Nasal Spray (0.1% azelastine hydrochloride)
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies
Completed
Meda Pharmaceuticals
Phase 3
2006-08-01
The Purpose of this study is to evaluate the safety and efficacy of MP03-36 (0.15% azelastine
hydrochloride)at dosages of 2 sprays per nostril once daily and 2 sprays per nostril twice
daily in patients with seasonal allergic rhinitis.
Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR
Completed
Novella Clinical
Phase 4
2013-06-01
The purpose of this study is to compare the safety of 2 different doses of the
investigational use of an allergy medication (Astepro Nasal Spray) in the treatment of
allergic rhinitis (AR). This is an open-label study; that is, parent and child will know
which group each is in.
Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR
Completed
Meda Pharmaceuticals
Phase 4
2013-06-01
The purpose of this study is to compare the safety of 2 different doses of the
investigational use of an allergy medication (Astepro Nasal Spray) in the treatment of
allergic rhinitis (AR). This is an open-label study; that is, parent and child will know
which group each is in.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
